IMARA

House mark for pharmaceutical preparations for genetic disorders, hematologic disorders, sickle-cell disease and thalassemia, all of the foregoing goods available by prescription only and all of the foregoing goods specifically excluding pharmaceutical preparations for use in oncology or for treatment of cancer